Germany · 
Who invested in Dopavision?
Dopavision's investors include Seventure Partners, Novartis and Boehringer Ingelheim Venture Fund.
Germany · Series A startup
Who invested in Dopavision
Funding summaryUpdated 26 Oct 2026
$14Mraised across 1 round since 2021, from 1 source
- Latest round
- Series A, $14MJul 2021
- Investors
- 3
The rounds
- Jul 2021
Founders and team
From Dopavision's own website: 3 founders, 4 on the team.
Christian LautnerCo-Founder
Dr. Hamed BahmaniFounder
Stefan ZundelCo-Founder
- Dr. Mark WuttkeChief Executive Officer
- Dr. Andreas BalserChief Technology Officer
- Dr. Gabriela BurianChief Medical Officer
- Dr. Dirk SauerBoard Chair
Everyone who backed them
Boehringer Ingelheim Venture FundCorporate VC1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Dopavision
How much has Dopavision raised?
Dopavision has raised $14M across 1 round since 2021.
When did Dopavision last raise?
Dopavision's most recent round was a Series A of $14M in Jul 2021.
What was Dopavision's biggest round?
Its most recent round, $14M in Jul 2021, is also its largest on record.
Who backed Dopavision first?
Dopavision's first round on record, in Jul 2021, was backed by Seventure Partners, Novartis and Boehringer Ingelheim Venture Fund.
What stage is Dopavision at?
Dopavision's latest named round is a Series A, in Jul 2021.
Where is Dopavision based?
Dopavision is based in Germany.
Companies like Dopavision
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.